UK Gov
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the classification of ganaxolone.
Ganaxolone is approved for marketing in the UK for the treatment of CDKL5, a rare epileptic seizure disorder. This letter provides advice on whether ganaxolone warrants control under the Misuse of Drugs Act 1971.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
